FCGTX | REGTX | FCGTX / REGTX | |
Total Expense Ratio | 0.36 | 0.41 | 88% |
Annual Report Gross Expense Ratio | 0.36 | 0.41 | 88% |
Fund Existence | 9 years | 19 years | - |
Gain YTD | 15.738 | 15.690 | 100% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 250 | 400,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 50B | 50B | 100% |
Annual Yield % from dividends | 1.41 | 1.35 | 104% |
Returns for 1 year | 14.64 | 14.60 | 100% |
Returns for 3 years | 46.71 | 46.67 | 100% |
Returns for 5 years | 44.16 | 44.15 | 100% |
Returns for 10 years | N/A | 96.39 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GLOW | 29.87 | 0.43 | +1.46% |
VictoryShares WestEnd Global Equity ETF | |||
QTEC | 219.92 | 2.00 | +0.92% |
First Trust NASDAQ-100-Tech Sector ETF | |||
LEO | 6.20 | 0.02 | +0.32% |
BNY Mellon Strategic Municipals | |||
BBC | 24.00 | -0.12 | -0.50% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
BMVP | 48.79 | -0.32 | -0.65% |
Invesco Bloomberg MVP Multi-factor ETF |